Closed call · historical reference

H2020-JTI-IMI2-2017-13-two-stage · Translational Safety Biomarker Pipeline (TransBioLine): Enabling development and implementation of novel safety biomarkers in clinical trials and diagnosis of disease

Specific Challenge:Early and reliable detection and monitoring of adverse events is essential for improving of patient safety, reducing late attrition of drug candidates, and enhancing understanding of toxic mechanisms. In particular, biomarkers that provide insights into mechanisms of tissue injur…